Gynecologic Oncology | Specialty

Taking Measures to Prevent Breast Cancer

April 5th 2011

A team of researchers explored the use of drugs in terms of breast cancer prevention strategies

Rocky Ride for Iniparib Not Yet Over

April 1st 2011

Iniparib remains an intriguing therapeutic possibility despite failing to meet its phase III primary endpoints

Dr. Twelves on the Value of the Iniparib Trial Results

April 1st 2011

Christopher Twelves, MD, Professor of Clinical Cancer Pharmacology and Oncology and Head of the Clinical Cancer Research Group at the University of Leeds in the United Kingdom on the Value of the Negative Iniparib Trial Results

Fewer Women Dying of Lung Cancer

April 1st 2011

For the first time in at least 3 decades, the rate of women dying from lung cancer in the United States is declining

Dr. Twelves on Negative Phase III Iniparib Announcements

April 1st 2011

Dr. Twelves Describes Iniparib Clinical Trials

April 1st 2011

March Net Guides: Ovarian Cancer

March 31st 2011

Useful Online Resources and Clinical Trials for Ovarian Cancer

Lymph Nodes Overlooked in Ovarian Cancer Patients

March 30th 2011

Women with early-stage ovarian cancer were nearly twice as likely to die if they did not have recommended staging biopsies of pelvic and aortic lymph nodes

Follow Up Treatment With Tamoxifen

March 29th 2011

Tamoxifen, a common drug used to treat breast cancer, works by blocking the effect of estrogen on tumor cells.

Sowing the Seeds From Alabama to Brazil

March 29th 2011

Like the Deep South Network for Cancer Control, the Sowing the Seeds of Health program relies on community health advisors to spread the word about cancer prevention and early detection

Barriers to Mammogram Completion Persist Despite Insurance Coverage and Reminder Programs

March 28th 2011

New research suggested that concern about pain may deter obese women from undergoing mammography, while a busy schedule may dissuade women aged less than 60 years

Dr. Tew Evaluates Avastin Treatment in Ovarian Cancer

March 24th 2011

William P. Tew, MD, a Gynecologic Medical Oncologist at Memorial Sloan-Kettering Cancer Center in New York, evaluates bevacizumab (Avastin) as a treatment for women with ovarian cancer

Study Indicates That Immigrant Women in Ontario Shun Cervical Cancer Screening

March 24th 2011

New data suggest that immigration status may help explain why some women decide to be screened for cervical cancer and others do not

Insured Women Are Skipping Mammograms at High Rates

March 22nd 2011

About 40% of insured women in the United States are not undergoing screening mammography at least every 2 years in keeping with guidelines from the USPSTF.

The Final Word on CYP2D6 Testing and Tamoxifen?

March 16th 2011

CYP2D6 phenotype status does not predict tamoxifen efficacy in patients with early-stage breast cancer, according to a retrospective analysis of data from the Breast International Group

Shedding More Light on Identifying HER2

March 16th 2011

Breast cancer researcher Edith A. Perez, MD, is aiming to present more detailed study findings at national conferences later this year that will help clinicians better identify patients who would benefit from HER2 targeted treatment.

Dear Kayla and Christopher: A Mom With Breast Cancer Documents Her Battle for Her 2 Young Children

March 15th 2011

It was 2 days after her very first mammogram when Lisa Vance got a call from her physician's office requesting that she come in to discuss the results. Even so, it never occurred to her to be worried.

The Longstanding Quest for a Better Endocrine Therapy Continues High-Dose Fulvestrant: Have We Found Its Effective Dose, Combination, Setting, or Sequence?

March 15th 2011

Although several endocrine therapies are available today, the authors of this commentary contend that the quest for a better tamoxifen is ongoing.

Dr. Tripathy on Bone Health in Breast Cancer Patients

March 15th 2011

Debu Tripathy, MD, Co-leader Women's Breast Cancer Program at USC/Norris Comprehensive Cancer Center, on bone health considerations for patients with breast cancer.

Dr. Tripathy Discusses Bisphosphonate Studies

March 15th 2011

Debu Tripathy, MD, Co-leader Women’s Breast Cancer Program at USC/Norris Comprehensive Cancer Center, discusses clinical research and studies looking at the use of bisphosphonate for women with breast cancer.